THRD

3.44

1.01% -0.04

After Hours: 3.44

Third Harmonic Bio Inc (THRD)

Overview News Price History Option Chain Financials Discussions Forecast

Third Harmonic Bio Inc stock is traded at $3.44, with a volume of 368.22K. It is down -1.01% in the last 24 hours and down -1.57% over the past month.

Previous Close:

$3.48

Open:

$3.38

24h Volume:

368.22K

Relative Volume:

0.61

Market Cap:

$156.96M

Revenue:

Net Income/Loss:

$-32.74M

P/E Ratio:

-4.1951

EPS:

-0.82

Net Cash Flow:

$-24.89M

1W Performance:

-0.72%

1M Performance:

-1.57%

6M Performance:

-72.01%

1Y Performance:

-67.80%

1-Day Range:

$3.30

$3.60

1-Week Range:

$3.30

$3.60

52-Week Range:

$3.18

$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name

Third Harmonic Bio Inc

Sector

Healthcare (1189)

Industry

Biotechnology (673)

Phone

(209) 727-2457

Address

1700 MONTGOMERY STREET, SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2025-03-26

Latest SEC Filings

THRD's Discussions on Twitter

Compare THRD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
THRD Third Harmonic Bio Inc	3.44	156.96M	0	-32.74M	-24.89M	-0.82
VRTX Vertex Pharmaceuticals Inc	474.56	121.88B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	572.78	62.69B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	550.00	32.85B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	232.95	28.75B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	220.54	25.69B	3.81B	-644.79M	-669.77M	-6.24

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-28-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-11-25	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-09-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-18-24	Initiated	Stifel	Buy
Jun-07-24	Initiated	Raymond James	Outperform
Dec-16-22	Downgrade	Jefferies	Buy → Hold
Dec-15-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-10-22	Initiated	Cowen	Outperform
Oct-10-22	Initiated	Jefferies	Buy
Oct-10-22	Initiated	Morgan Stanley	Overweight

View All

Third Harmonic Bio Inc Stock (THRD) Latest News

Apr 04, 2025

Fierce Biotech Layoff Tracker 2025: Relay sheds staff again; Sail lays off employees - Fierce Biotech

Apr 04, 2025

Mar 31, 2025

Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 29, 2025

Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks

Mar 29, 2025

Stifel Downgrades Third Harmonic Bio (THRD) - MSN

Mar 29, 2025

Mar 28, 2025

Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener

Mar 28, 2025

Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks

Mar 28, 2025

Mar 27, 2025

Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks

Mar 27, 2025

Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com

Mar 27, 2025

Third Harmonic Bio Q4 Net Income USD -13.1 Million - Marketscreener.com

Mar 27, 2025

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Mar 27, 2025

Third Harmonic Bio, Inc. Announces Rise In Full Year Profit - Nasdaq

Mar 27, 2025

Third Harmonic's $285M War Chest Powers Phase 2 CSU Drug Development Amid Strategic Shift - Stock Titan

Mar 27, 2025

Mar 21, 2025

Third Harmonic Bio Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 21, 2025

Mar 19, 2025